🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07333989
Recruiting Not applicable

Effect of Biofeedback Activation on Balance in Osteoporotic Elderly

NCT07333989 · tracked via the Priya Life Science Egypt tracker
Sponsor
Mohamed Said Alsafy Alhamrawy
Phase
Not applicable
Started
2026-01-02
Last updated
2026-03-20

Condition(s) studied

Balance ProblemsElderly (People Aged 65 or More)

Investigational drug(s) / intervention(s)

Electromyographic (EMG) biofeedbackBalance training

Electromyographic (EMG) biofeedback: a physical therapy intervention that uses auditory and visual feedback to control the contraction or relaxation of muscles. Repeated biofeedback training can induce motor learning of muscles. Biofeedback enhances the function of pelvic floor muscles by enhancing the force generation, correct timing, and coordination of the pelvic floor muscles. Electromyography Biofeedback is considered as a behavioural therapy training modality

Balance training: functional strength, static and dynamic balance, and gait training

Study summary

This study aimed to investigate the effect of gluteus medius activation using electromyography (EMG) biofeedback combined with balance training on balance, physical performance, gluteus medius muscle activity, and quality of life in osteoporotic elderly patients.

Eligibility

Sex
ALL
Min age
65 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * All patients included in this study met the following criteria: 1. Sixty patients of both sexes were diagnosed with osteoporosis confirmed by bone density test through Dual-energy X-ray absorptiometry (DEXA) scan (A T-score equal to or less than - 2.5) (Sheu and Diamond, 2016). 2. Their age ranged between 65 - 75 years. 3. Their BMI ranged between 25 - 29.9 kg/m2. 4. They had good mentality and cognitive function. Exclusion Criteria: * The potential patients were excluded if they have one of the following criteria: 1. Patients with endocrine disorders likely to be related to metabolic bone disease, such as premature ovarian failure, hypogonadism, untreated hyperthyroidism, hyperparathyroidism, adrenal insufficiency or Cushing's syndrome. 2. Patients with active contagious skin conditions. 3. Patients with implant devices such as pacemaker or electrical prosthesis. 4. Any cardiopulmonary disorders. 5. Any neuromuscular disorders. 6. Any acute viral infection. 7. Patients with ascites or end stage liver or kidney failure. 8. Leg discrepancy.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
General Hospital Abouhms Abū Ḩummuş Egypt Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07333989 on ClinicalTrials.gov ↗ ← All trials in Egypt